A detailed history of Rock Point Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Rock Point Advisors, LLC holds 6,033 shares of JNJ stock, worth $881,783. This represents 0.29% of its overall portfolio holdings.

Number of Shares
6,033
Previous 5,933 1.69%
Holding current value
$881,783
Previous $929,000 2.69%
% of portfolio
0.29%
Previous 0.29%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$155.22 - $162.74 $15,522 - $16,274
100 Added 1.69%
6,033 $954,000
Q3 2023

Nov 09, 2023

SELL
$155.75 - $174.48 $23,362 - $26,172
-150 Reduced 2.47%
5,933 $924,000
Q2 2023

Aug 10, 2023

BUY
$154.35 - $166.11 $108,045 - $116,277
700 Added 13.0%
6,083 $1.01 Million
Q1 2023

May 10, 2023

SELL
$151.05 - $180.26 $49,846 - $59,485
-330 Reduced 5.78%
5,383 $834,000
Q3 2022

Nov 10, 2022

SELL
$161.33 - $179.52 $98,411 - $109,507
-610 Reduced 9.65%
5,713 $933,000
Q2 2022

Aug 10, 2022

SELL
$168.19 - $186.01 $17,828 - $19,717
-106 Reduced 1.65%
6,323 $1.12 Million
Q1 2022

May 10, 2022

SELL
$158.14 - $179.59 $25,144 - $28,554
-159 Reduced 2.41%
6,429 $1.14 Million
Q4 2021

Feb 09, 2022

BUY
$155.93 - $173.01 $13,877 - $15,397
89 Added 1.37%
6,588 $1.13 Million
Q4 2020

Feb 08, 2021

SELL
$137.11 - $157.38 $6,307 - $7,239
-46 Reduced 0.7%
6,499 $1.02 Million
Q3 2020

Nov 10, 2020

SELL
$140.38 - $153.83 $47,588 - $52,148
-339 Reduced 4.92%
6,545 $974,000
Q2 2020

Aug 12, 2020

SELL
$128.81 - $155.51 $36,324 - $43,853
-282 Reduced 3.94%
6,884 $968,000
Q1 2020

May 07, 2020

SELL
$111.14 - $153.99 $74,686 - $103,481
-672 Reduced 8.57%
7,166 $940,000
Q4 2019

Feb 06, 2020

BUY
$127.5 - $146.44 $21,547 - $24,748
169 Added 2.2%
7,838 $1.14 Million
Q3 2019

Nov 08, 2019

BUY
$126.95 - $142.14 $27,040 - $30,275
213 Added 2.86%
7,669 $992,000
Q1 2019

May 08, 2019

SELL
$125.72 - $139.79 $24,892 - $27,678
-198 Reduced 2.59%
7,456 $1.04 Million
Q4 2018

Jan 31, 2019

BUY
$122.84 - $147.84 $12,775 - $15,375
104 Added 1.38%
7,654 $988,000
Q3 2018

Nov 07, 2018

SELL
$121.58 - $142.88 $21,884 - $25,718
-180 Reduced 2.33%
7,550 $1.04 Million
Q2 2018

Aug 09, 2018

BUY
$119.4 - $131.76 $42,984 - $47,433
360 Added 4.88%
7,730 $938,000
Q1 2018

May 11, 2018

SELL
$125.1 - $148.14 $5,004 - $5,925
-40 Reduced 0.54%
7,370 $944,000
Q4 2017

Feb 09, 2018

BUY
$131.22 - $143.62 $54,587 - $59,745
416 Added 5.95%
7,410 $1.04 Million
Q3 2017

Nov 03, 2017

BUY
$129.47 - $135.38 $905,513 - $946,847
6,994
6,994 $909,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $382B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Rock Point Advisors, LLC Portfolio

Follow Rock Point Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Point Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rock Point Advisors, LLC with notifications on news.